(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
Update Venetoclax in CLL
Acalabrutinib
Cancer.gov
ASH: COVID-19 Resources for Managing Blood Cancers
Patient Power
NCCN Guidelines for Patients